

|
Email:
|
emilia.hijova@upjs.sk | |
|
Homepage:
|
https://www.upjs.sk/LF/zamestnanec/emilia.hijova | |
|
Faculty:
|
LF UPJŠ
-
Pavol Jozef Šafárik University in Košice Faculty of Medicine
|
|
|
Department:
|
CKPV
-
Center of Clinical and Preclinical Research MEDIPARK
|
|
|
Office:
|
MB6O20 | |
|
Phone:
|
+421 55 234 3463 | |
|
ORCID ID:
|
0000-0002-8259-373X |
|
Selected publications
|
|
Hijová, E., Bertková, I., Benetinová, V.: Gut Microbiota as an Innovative Therapeutic Target in Cardiovascular Diseases from a Metabolic and Inflammatory Perspective. Biomedicines, 2026,14,6, 1267 (1-27). IF-4,5; Q1 |
|
Hijová, E., Bertková, I., Štofilová, J.: Incorporating Postbiotics into Intervention for Managing Obesity, International Journal of Molecular Sciences, 2025,26,11,5326 (1-23). IF-5,6; Q1 |
|
Hijová, E. Probiotic in IBD : Evidence and Perspectives on Patient Health and Disease Management. International Journal of Molecular Sciences, 2025,16,18,9065 (1-26). IF-5,6; Q1 |
|
Hijová, E.: Postbiotics as Metabolites and Their Biotherapeutic Potential, International Journal of Molecular Sciences, 2024,25,10,5441 (1-22), IF-4,9; Q1 |
|
Hijová, E.: Benefits of biotics for cardiovascular disesaes. International Journal of Molecular Sciences, 2023,24,7,6292 (1-18). IF-4,9; Q1 |
|
Selected projects
|
|
NFP401101C030-PERBIOKARDIO Inovatívny prístup vo výskume črevného mikrobiómu a vývoji personalizovaných probiotík pre pacientov s kardiovaskulárnymi ochoreniami. Zodpovedný riešiteľ: RNDr. Jana Štofilová, PhD. An innovative approach to gut microbiome research and the development of personalized probiotics for patients with cardiovascular diseases. Principal Investigator: RNDr. Jana Štofilová, PhD. |
|
APVV-23-0354 Personalizovaný prístup k selekcii a aplikácii efektívnych probiotík a synbiotík v manažmente obezity. Zodpovedný riešiteľ: RNDr. Izabela Bertková, PhD. Personalized approach to the selection and application of effective probiotics and synbiotics in obesity management. Principal Investigator: RNDr. Izabela Bertková, PhD. |
|
APVV-23-0031 Transplantácia fekálnej mikrobioty a jej potenciálne využitie pri nešpecifických zápalových ochoreniach čriev v humánnej a veterinárnej medicíne. Zodpovedný riešiteľ: MVDr. Soňa Gancarčíková, PhD. Fecal microbiota transplantation and its potential application in inflammatory bowel diseases in human and veterinary medicine. Principal Investigator: MVDr. Soňa Gancarčíková, PhD. |
|
VEGA -1/0253/25 Inovatívny prístup v terapii črevných zápalových ochorení-cielené probiotiká a synbiotiká. Zodpovedný riešiteľ: RNDr. Jana Štofilová, PhD. An innovative approach to the therapy of inflammatory bowel diseases – targeted probiotics and synbiotics. Principal Investigator: RNDr. Jana Štofilová, PhD. |
|
VEGA -1/0232/25 Predklinický molekulárno-biologický výskum účinku probiotík a synbiotík na báze Limosilactobacillus fermentum na cielenú podporu funkčnosti črevnej bariéry. Zodpovedný riešiteľ: RNDr. Anna Kamlárová, PhD. Preclinical molecular-biological research on the effects of probiotics and synbiotics based on *Limosilactobacillus fermentum* for the targeted support of intestinal barrier function. Principal Investigator: RNDr. Anna Kamlárová, PhD. |
|
Projects
|
|
Project of Structural Funds EU: Drive4SIFood (ITMS 2014+ 313011V336) Demand-driven research for sustainable and innovative food (2019-2023) PROBIO-3 (ITMS 313011T651) Bioactive substances for health promotion and prevention of chronic diseases (2016-2019) PROBIO (ITMS 26220220104) Probiotic microorganisms and bioactive substances of natural origin for a healthier population of Slovakia (2011-2015) PROBIOTECH (ITMS 26220220152) Competence Center for Biomodulators and Nutritional Supplements (2011-2015) CEMIO (ITMS 26220120058) Center of Excellence for Health Factors Research Focusing on a Group of Marginalized and Immunocompromised People (2010-2013)
|
